目的：比较特比萘芬片剂和伊曲康唑胶囊治疗甲真菌病的有效性和安全性。
AIM: To compare the efficacy and safety of terbinafine and intraconazole in the treatment of onychomycosis.
目的评价甲真菌病临床评分指数(SCIO)指导伊曲康唑冲击和特比萘芬连续疗法治疗甲真菌病的疗效、安全性及费用疗效比。
Objective To assess the efficacy, safety and cost-effectiveness of itraconazole and terbinafine for the treatment of onychomycosis, evaluated by the scoring clinical index of onychomycosis (SCIO).
口服伊曲康唑和5氟胞嘧啶有明显效果。
The patient received oral itraconazole and 5 FC and showed favorable effect.
预防性静脉滴注伊曲康唑组其血清GM含量和组织真菌负荷量比对照组明显降低。
Serum GM index and fungal CFU in tissues were also markedly reduced in prophylactic itraconzole group.
本发明提供吡咯抗微生物药物诸如伊曲康唑、沙康唑、酮康唑和氟 康唑的口服药物制剂。
The present invention provides oral pharmaceutical formulation for azole antimicrobial drugs such as itraconazole, saperconazole, ketoconazole, and fluconazole.
伊曲康唑和特比萘芬有较好的药代学特性，特别是通过口服给药随血运达甲床，进而渗透进入甲板，起抑杀真菌效果。
With the good pharmacokinetic properties of itraconazole and terbinafine, by oral route effective concentration of the two drugs can be obtained in nail bed and then be diffused into nail plate.
90年代在抗真菌药上有很大进展，主要是三唑类的伊曲康唑和氟康唑。
Most of the advances in the 1990s have been tied to the introduction of triazoles:itraconazole and fluconazole.
摘要目的：评价伊曲康唑冲击疗法治疗由皮肤癣菌、酵母菌和霉菌引起的甲真菌病的有效性、安全性和耐受性。
Abstract Objective: to evaluate the efficacy, safety and tolerability of itraconazole pulse therapy for onychomycosis due to dermatophytes, yeasts and molds.
摘要目的：评价伊曲康唑冲击疗法治疗由皮肤癣菌、酵母菌和霉菌引起的甲真菌病的有效性、安全性和耐受性。
Abstract Objective: to evaluate the efficacy, safety and tolerability of itraconazole pulse therapy for onychomycosis due to dermatophytes, yeasts and molds.
应用推荐